Week in review: Alembic equivalent, microglia biosensors, quantum dots

• Posted on: Apr 26 2019
• By: Saratoga Opthalmology
• Leave a response

This week, Alembic’s tobramycin ointment gains FDA approval, microglia limit damage after retinal detachment and quantum dots could combat retinitis pigmentosa.
Source: AAO

Posted in: Uncategorized